Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elevance Health, Inc. Common Stock (NY:ELV)

277.09 -25.36 (-8.38%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The weekly Stock Whisper Index highlights five stocks seeing increased interest from Benzinga readers. 
Via Benzinga
AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
From AREX Capital Management, LP
Via GlobeNewswire
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 5 Years
Via Benzinga
Top 4 Health Care Stocks That May Plunge This Month
Via Benzinga
Looking Into Elevance Health's Recent Short Interest
Via Benzinga
Decoding 13 Analyst Evaluations For Elevance Health
Via Benzinga
Elevance Health Analysts Boost Their Forecasts After Upbeat Earnings
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $11,000 Today
Via Benzinga
Deep Dive Into Elevance Health Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
3 Healthcare Stocks to Buy Now: Q2 Edition
Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now. 
Via InvestorPlace
Tracking Last Week's Top Performers: Are These 7 Large-Cap Stocks In Your Portfolio?
Last week's top performers included United Airlines, Bentley Systems, Progressive Corp and Morgan Stanley. 
Via Benzinga
Elevance Health (ELV) Q1 2024 Earnings Call Transcript
ELV earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
ELV Stock Earnings: Elevance Health Beats EPS, Misses Revenue for Q1 2024
ELV stock results show that Elevance Health beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual Guidance
Elevance Health reports Q1 revenues at $42.3 billion, surpassing expectations. CEO Gail Boudreaux highlights strategic growth initiatives, with profit up 12.2% Y/Y and adjusted EPS at $10.64. Medicaid... 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
Via Benzinga
How Is The Market Feeling About Elevance Health?
Via Benzinga
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Earnings Scheduled For April 18, 2024
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter. 
Via Benzinga
Elevance Health Reports First Quarter 2024 Results
From Elevance Health, Inc.
Via Business Wire
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
Florida announces Medicaid contract awards to Centene, Elevance Health, and Humana, sidelining UnitedHealth, CVS Health, and Molina. Details on MMA and LTC services for over 3.4 million Floridians... 
Via Benzinga
Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
From Elevance Health, Inc.
Via Business Wire
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
From Elevance Health, Inc.
Via Business Wire
Israel Kills Top Iranian General – Oil Rises – Not Great For Stock Market's No Inflation Story
To gain an edge, this is what you need to know today. Raise Hedges It is time to raise hedges.  As full disclosure, a signal was given to The Arora Report members. 
Via Benzinga
Topics Economy
UnitedHealth, Health Insurers Tumble On Medicare Advantage Rates
Final Medicare Advantage rates were unchanged vs. the initial proposal. 
Via Investor's Business Daily
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows
Study reveals stark contrast: Novo Nordisk's Ozempic diabetes drug costs nearly $1,000 monthly in the U.S., yet could be produced for less than $5. This underscores the affordability challenge faced by... 
Via Benzinga
Insurance Coverage For Weight Loss Drugs - Elevance, CVS Health Become First To Extend Coverage To Novo Nordisk's Successful Wegovy For Certain Patients
Major U.S. health insurers CVS Health, Elevance Health, and Kaiser Permanente now reimburse for Novo Nordisk's Wegovy for specific Medicare individuals with heart-related conditions. This shift aims to... 
Via Benzinga
3 Stocks To Buy For Decreased Volatility
Here are three low-beta stocks that could all be considered for those looking for a more conservative approach. 
Via Talk Markets
3 Stocks To Buy For Decreased Volatility
Beta measures a stock's volatility in comparison to a relevant benchmark. The market, such as the S&P 500 Index, has a beta of 1.0. 
Via Talk Markets
Topics Stocks
Kroger Passes The Baton: Sells Specialty Pharmacy Division To CarelonRx
Kroger sells specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, for undisclosed amount. Deal expected to close in 2nd half of 2024, will not impact 2024 guidance. 
Via Benzinga
Elevance Health Announces Closing of Paragon Healthcare Acquisition
From Elevance Health, Inc.
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.